Pharmacokinetic model for tobramycin in acinetobacter meningitis

scientific article published in January 2002

Pharmacokinetic model for tobramycin in acinetobacter meningitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1345/APH.19114
P8608Fatcat IDrelease_v7hbqxoq2zhvjmnfspjfnjmnja
P698PubMed publication ID11816266

P2093author name stringEva Romá-Sánchez
Ana-Cristina Cercós-Lletí
Pedro V Chicano-Piá
P2860cites workExperience with a once-daily aminoglycoside program administered to 2,184 adult patientsQ39779327
Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitisQ40968557
Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysisQ40988370
Single or multiple daily doses of aminoglycosides: a meta-analysisQ42145555
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentrationQ44483617
Pharmacokinetic optimisation of the treatment of bacterial central nervous system infectionsQ48369007
Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.Q48385324
Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli.Q52034877
Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarineQ52437136
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmeningitisQ48143
pharmacokineticsQ323936
P304page(s)83-86
P577publication date2002-01-01
P1433published inAnnals of PharmacotherapyQ4767858
P1476titlePharmacokinetic model for tobramycin in acinetobacter meningitis
P478volume36